Logo image of VERU

VERU INC (VERU) Stock Fundamental Analysis

NASDAQ:VERU - Nasdaq - US92536C1036 - Common Stock

1.08  -0.01 (-0.92%)

Fundamental Rating

2

VERU gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 37 industry peers in the Personal Care Products industry. The financial health of VERU is average, but there are quite some concerns on its profitability. VERU is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

VERU had negative earnings in the past year.
VERU had a negative operating cash flow in the past year.
In the past 5 years VERU reported 4 times negative net income.
In the past 5 years VERU always reported negative operating cash flow.
VERU Yearly Net Income VS EBIT VS OCF VS FCFVERU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

Looking at the Return On Assets, with a value of -62.57%, VERU is doing worse than 83.33% of the companies in the same industry.
VERU's Return On Equity of -116.97% is on the low side compared to the rest of the industry. VERU is outperformed by 77.78% of its industry peers.
Industry RankSector Rank
ROA -62.57%
ROE -116.97%
ROIC N/A
ROA(3y)-103.45%
ROA(5y)-68.61%
ROE(3y)-231.35%
ROE(5y)-150.44%
ROIC(3y)N/A
ROIC(5y)N/A
VERU Yearly ROA, ROE, ROICVERU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

With a Gross Margin value of 34.66%, VERU is not doing good in the industry: 80.56% of the companies in the same industry are doing better.
VERU's Gross Margin has declined in the last couple of years.
VERU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.76%
GM growth 5Y-12.64%
VERU Yearly Profit, Operating, Gross MarginsVERU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

4

2. Health

2.1 Basic Checks

VERU does not have a ROIC to compare to the WACC, probably because it is not profitable.
VERU has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, VERU has more shares outstanding
VERU has a better debt/assets ratio than last year.
VERU Yearly Shares OutstandingVERU Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
VERU Yearly Total Debt VS Total AssetsVERU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

VERU has an Altman-Z score of -4.76. This is a bad value and indicates that VERU is not financially healthy and even has some risk of bankruptcy.
VERU has a Altman-Z score of -4.76. This is amonst the worse of the industry: VERU underperforms 91.67% of its industry peers.
A Debt/Equity ratio of 0.27 indicates that VERU is not too dependend on debt financing.
VERU has a Debt to Equity ratio of 0.27. This is comparable to the rest of the industry: VERU outperforms 47.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z -4.76
ROIC/WACCN/A
WACC9.04%
VERU Yearly LT Debt VS Equity VS FCFVERU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

VERU has a Current Ratio of 2.97. This indicates that VERU is financially healthy and has no problem in meeting its short term obligations.
VERU has a better Current ratio (2.97) than 80.56% of its industry peers.
A Quick Ratio of 2.62 indicates that VERU has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.62, VERU belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.97
Quick Ratio 2.62
VERU Yearly Current Assets VS Current LiabilitesVERU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 76.01% over the past year.
Looking at the last year, VERU shows a small growth in Revenue. The Revenue has grown by 3.62% in the last year.
VERU shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.89% yearly.
EPS 1Y (TTM)76.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.47%
Revenue 1Y (TTM)3.62%
Revenue growth 3Y-34.92%
Revenue growth 5Y-11.89%
Sales Q2Q%72.36%

3.2 Future

VERU is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.05% yearly.
Based on estimates for the next years, VERU will show a very strong growth in Revenue. The Revenue will grow by 63.28% on average per year.
EPS Next Y3.36%
EPS Next 2Y-11.93%
EPS Next 3Y-5.51%
EPS Next 5Y3.05%
Revenue Next Year-33.41%
Revenue Next 2Y-34.03%
Revenue Next 3Y-17.17%
Revenue Next 5Y63.28%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VERU Yearly Revenue VS EstimatesVERU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M
VERU Yearly EPS VS EstimatesVERU Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

VERU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year VERU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VERU Price Earnings VS Forward Price EarningsVERU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VERU Per share dataVERU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2

4.3 Compensation for Growth

A cheap valuation may be justified as VERU's earnings are expected to decrease with -5.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.93%
EPS Next 3Y-5.51%

More info and screens

0

5. Dividend

5.1 Amount

VERU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VERU INC

NASDAQ:VERU (1/22/2025, 11:51:06 AM)

1.08

-0.01 (-0.92%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)12-05 2024-12-05/amc
Earnings (Next)02-05 2025-02-05/bmo
Inst Owners37.79%
Inst Owner Change0.33%
Ins Owners10.62%
Ins Owner Change0%
Market Cap158.09M
Analysts81.82
Price Target3.47 (221.3%)
Short Float %10.28%
Short Ratio8.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)47.04%
Min Revenue beat(2)10.75%
Max Revenue beat(2)83.32%
Revenue beat(4)3
Avg Revenue beat(4)22.02%
Min Revenue beat(4)-41.15%
Max Revenue beat(4)83.32%
Revenue beat(8)4
Avg Revenue beat(8)1.72%
Revenue beat(12)6
Avg Revenue beat(12)-8.13%
Revenue beat(16)8
Avg Revenue beat(16)-3.95%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)37.5%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-56.5%
Revenue NY rev (1m)-28.17%
Revenue NY rev (3m)-28.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.36
P/FCF N/A
P/OCF N/A
P/B 4.89
P/tB 6.21
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0.12
BVpS0.22
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -62.57%
ROE -116.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.66%
FCFM N/A
ROA(3y)-103.45%
ROA(5y)-68.61%
ROE(3y)-231.35%
ROE(5y)-150.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.76%
GM growth 5Y-12.64%
F-Score4
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 59.04%
Cap/Sales 0.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.97
Quick Ratio 2.62
Altman-Z -4.76
F-Score4
WACC9.04%
ROIC/WACCN/A
Cap/Depr(3y)217.78%
Cap/Depr(5y)171.54%
Cap/Sales(3y)2.29%
Cap/Sales(5y)1.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.47%
EPS Next Y3.36%
EPS Next 2Y-11.93%
EPS Next 3Y-5.51%
EPS Next 5Y3.05%
Revenue 1Y (TTM)3.62%
Revenue growth 3Y-34.92%
Revenue growth 5Y-11.89%
Sales Q2Q%72.36%
Revenue Next Year-33.41%
Revenue Next 2Y-34.03%
Revenue Next 3Y-17.17%
Revenue Next 5Y63.28%
EBIT growth 1Y61.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y75.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.36%
OCF growth 3YN/A
OCF growth 5YN/A